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Abstract: The marine alkaloids (–)-lepadins A–C and (+)-lepadin D, 
belonging to two diastereoisomeric series, were synthesized from an 
(R)-phenylglycinol-derived tricyclic lactam via a common cis-
decahydroquinoline intermediate. Crucial aspects of the synthesis 
are the stereochemical control in the assembly of the cis- 
decahydroquinoline platform, in the introduction of the C-2 methyl 
and C-3 hydroxy substituents, and in the generation of the C-5 
stereocenter.  
Introduction 
Decahydroquinoline (DHQ) alkaloids constitute an important 
group of natural products, which exhibit a wide range of 
biological activities. Rather than in plants, they occur mainly in 
other terrestrial (amphibians, arthropods) and marine (tunicates, 
flatworms) organisms.[1] Most of these alkaloids are 2,5-
disubstituted DHQs (for instance, pumiliotoxin C, the most 
representative member of this group), but they also include 5,7-
disubstituted (the phlegmarine-type Lycopodium alkaloids)[2] and 
2,3,5-trisubstituted derivatives (lepadins). The latter are a 
relatively small group of cis-DHQ alkaloids isolated from marine 
sources, characterized by a C-2 methyl substituent, a C-3 
oxygenated (hydroxy or acyloxy) group, and a C-5 functionalized 
eight-carbon chain. From the stereochemical standpoint, 
lepadins can be classified into three series, as shown in Figure 1. 
The first isolation of a member of this group, lepadin A, was 
reported by Steffan in 1991[3] from the tunicate Clavelina 
lepadiformis. A few years later, Andersen et al. described the 
isolation of lepadins A–C from the flatworm Prostheceraeus 
villatus and its prey C. lepadiformis.[4] Lepadins A and B were 
found to exhibit significant in vitro cytotoxicity against several 
human cancer cell lines. Then in 2002, Wright and coworkers 
reported the isolation of lepadins D–F from the tunicate 
Didemnum sp.[5] and Carroll et al., lepadins F–H from the 
Australian ascidian Aplidium tabascum.[6,7] Lepadins D–F 
possess significant and selective antiplasmodial and 
antitrypanosomal actvivity. Their low cytotoxicity makes them 
attractive models for the development of new antimalarial agents.  
 
Figure 1. Lepadin alkaloids. 
 
More recently, lepadin B was found to block neuronal nicotinic 
acetylcholine receptors.[8] However, extensive bioactivity studies 
with lepadin alkaloids have been thwarted by the minute 
amounts isolated from natural sources. 
Several enantioselective total syntheses of lepadins have 
been reported so far,[9,10] which have allowed the relative and 
absolute configuration of these alkaloids to be unequivocally 
established. All these syntheses involve two phases: i) 
construction of a protected 3-hydroxy-2-methyl-cis-
hydroquinoline platform, either functionalized at C-5 or bearing 
an oxidized one-carbon substituent at this position, and ii) 
installation of the appropriate C-5 eight-carbon chain. A variety 
of methodologies have been developed for the first phase: 
closure of the carbocyclic ring by aldol cyclization[9a,b] or a ring-
closing/ring-opening metathesis sequence;[9d] closure of the 
piperidine ring by intermolecular [3+3]-azacycloaddition,[9f,g,11] 
xanthate-mediated free radical cyclization,[10] or alkylative 
cyclization processes;[9c] and sequential one-pot construction of 
both rings from an acyclic precursor by a tandem ene-yne-ene 
ring-closing metathesis.[9e] 
On the other hand, different strategies have been used to 
assemble the eight-carbon chain at the DHQ C-5 position: i) 
starting from a C-5 unsubstituted DHQ, direct introduction of an 
eight-carbon chain (C0+C8 strategy),[9d] or sequential introduction 
of either one carbon and a seven-carbon chain (C0+C1+C7)[9a,c] 
or two and six carbons (C0+C2+C6);[9c,f,g] ii) starting from a DHQ 
bearing a functionalized one-carbon substituent at C-5, direct 
elongation of a seven-carbon chain (C1+C7 strategy)[9e] or 
sequential elongation of one carbon and a six-carbon chain 
(C1+C1+C6).[9b] 
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Results and Discussion 
In previous work, we have developed straightforward procedures 
for the enantioselective synthesis of cis-DHQs bearing 
substituents at the 2-, 5-, and 6-positions, for instance the 
dendrobatid alkaloid (–)-pumiliotoxin C, using phenylglycinol-
derived oxazoloquinolone lactams A as enantiomeric 
scaffolds[12] (Scheme 1). These lactams are easily accessible by 
a stereoselective cyclocondensation reaction between (R)-
phenylglycinol and appropriate cyclohexenone-derived δ-keto 
esters.[13] 
Scheme 1. Enantioselective access to substituted cis-decahydroquinolines 
from oxazoloquinolone lactams.  
 
We envisaged tricyclic lactams A as suitable synthetic 
precursors of lepadins A–C and D, E, H, belonging to two 
different stereochemical series. Starting from a lactam B (A; R1 
= CH2OProt, R2 = H), bearing an oxidized one-carbon 
substituent at the quinoline C-5 position, after stereoselective 
hydrogenation of the C–C double bond and reductive removal of 
the oxazolidine ring, the stereoselective introduction of the 
methyl and hydroxy substituents, taking advantage of the lactam 
functionality, would give rise to a cis-DHQ C, which was 
visualized as a common intermediate en route to lepadins A–E 
and H (Scheme 2). 
Scheme 2. Synthetic strategy. 
 
The synthesis of (–)-lepadins A–C from C would involve the 
inversion of the configuration of the DHQ C-3 position and the 
elongation of the C-5 side chain.[14] In turn,  an inversion of the 
configuration at C-5 followed by the elongation of the C-5 chain 
would afford (+)-lepadin D and their acylated derivatives (–)-
lepadin E and (+)-lepadin H.  
Scheme 3 outlines the initial steps of the synthesis. The 
required δ-keto ester 3, bearing a trimethylsilylethyl (TMSE)-
protected hydroxymethyl substituent, was prepared in two steps 
from diketo ester 1, by Pd-catalyzed cross-coupling of either the 
corresponding vinyl triflate or, more conveniently, bromo enone 
with potassium alkoxymethyltrifluoroborate 2[15] (Scheme 3). 
 
Scheme 3. Initial steps of the synthesis.  
 
A cyclocondensation reaction of δ-keto ester 3 with (R)-
phenylglycinol, followed by catalytic hydrogenation of the 
resulting mixture of endocyclic and exocyclic unsaturated 
lactams led to saturated tricyclic lactam 4 in 67% overall yield.[16]  
The reductive opening of the oxazolidine ring was 
accomplished with complete retention of configuration by alane 
reduction, which also caused the reduction of the lactam 
carbonyl. A subsequent hydrogenolysis of the benzylic C–N 
bond in the presence of Boc2O stereoselectively gave cis-DHQ 5 
in 75% overall yield. Although the use of the above sequence 
requires an additional oxidation step to recover the lactam 
functionality, it ensures the cis DHQ ring fusion characteristic of 
lepadins.[17] The lactam carbonyl was efficiently reinstalled by 
ruthenium-promoted oxidation,[18] although these conditions 
unexpectedly caused the concomitant oxidation of the 
silylethoxy moiety to give lactam ester 6. 
To overcome this inconvenience, the TMSE protecting group 
was replaced by TIPS[19] as shown in Scheme 4 and, 
satisfactorily, the ruthenium-mediated oxidation of the TIPS-
substituted DHQ 7 afforded lactam 8 in nearly quantitative yield.  
Following our synthetic plan, the next step of the synthesis 
was the stereoselective introduction of the C-2 methyl and C-3 
hydroxy substituents. This was achieved in three steps, via the 
enecarbamate 10, which was prepared by treatment of lactam 8  






Scheme 4. Access to the advanced common intermediate 11.   
 
with Comins’ triflating reagent[20] followed by reaction of the 
resulting vinyl triflate 9 with Me2CuLi[21] (Scheme 4). 
A subsequent hydroboration-oxidation sequence using 
BH3·SMe2 complex[22] and trimethylamine N-oxide[22,23] 
stereoselectively provided the C-2/C-3 trans alcohol 11 (C, Prot 
= TIPS) in 84% overall yield from 9. The formation of a single 
stereoisomer in the process is a consequence of borane 
approaching the most accessible face of the double bond of 10, 
which adopts a conformation with an axial C8-C8a bond to avoid 
the A(1,3) strain caused by the Boc substituent. 
The inversion of the C-3 configuration, required for the 
synthesis of lepadins A–C from intermediate 11, was 
accomplished in 84% yield by Dess-Martin oxidation followed by 
NaBH4 reduction of the resulting ketone 12, which occurred 
stereoselectively from the less hindered face of the carbonyl 
group (Scheme 5). After protection of the C-3 hydroxy group of 
13 as an acetate, and conversion of the protected 
hydroxymethyl substituent into a formyl group, the required E,E-
configurated eight-carbon chain at C-5 was directly assembled, 
in a stereoselective manner, from aldehyde 14 by the Horner-
Wadsworth-Emmons methodology using the anion derived from 
diethyl (E)-hept-2-enylphosphonate (15) (C1+C7 strategy). 
Scheme 5 Inversion of the C-3 configuration and elongation of the C-5 side 
chain. Enantioselective synthesis of (–)-lepadins A and B.  
Diene 16, in which deprotection of the C-3 hydroxy group had 
occurred, was obtained in 52% overall yield from 13. A final 
removal of the Boc protecting group gave (–)-lepadin B. The 
synthesis of 16 also constitutes a formal total synthesis of (–)-
lepadin A.[9b,c] 
The NMR data of our synthetic (–)-lepadin B were coincident 
with those reported in the literature, while its specific rotation 
was in good agreement with the value reported for this 
compound.[9a] The synthesis of (–)-lepadin B consists of 19 
synthetic steps from δ-keto ester 3 and takes place in 7.6% 
overall yield, which represents a significant improvement with 
regard to previous syntheses of this alkaloid. 
Starting from the above aldehyde 14, a similar Horner-
Wadsworth-Emmons reaction using the functionalized 
phosphonate 17, led to 18, a known precursor[9c] of (–)-lepadin C 
(Scheme 6).  
 
Scheme 6. Elongation of the C-5 side chain. Enantioselective synthesis of (–)-
lepadin C. 
 
The key step to access lepadin D, and the configurationally 
related lepadins E and H, from the common intermediate 11 was 
the inversion of the C-5 configuration. To accomplish this, we 
envisaged a synthetic sequence involving the stereoselective 
hydrogenation of a substituted DHQ, such as 20a, bearing an 
exocyclic double bond at the C-5 position. In this way, the eight-
carbon chain would be assembled in two phases (C1+C2+C5 
strategy). Following the same three-step sequence used for the 
above conversion 13→14, alcohol 11 was converted to aldehyde 
19a in excellent overall yield (Scheme 7).  
 






Scheme 7. Inversion of the C-5 configuration and two-carbon elongation. 
 
An initial two-carbon elongation by Wittig olefination with 
(ethoxycarbonylmethylene)triphenylphosphorane, followed by 
base-promoted isomerization of the resulting conjugated 
carbon–carbon double bond to an exocyclic position[24] led to 
unsaturated ester 20a.[25,26] After removal of the Boc protecting 
group,[27] catalytic hydrogenation of the resulting secondary 
amine (as hydrochloride[28]) in AcOH stereoselectively installed 
the required C-5 stereochemistry. A subsequent protection with 
Boc2O afforded 21a.[29]  
A notable improvement in terms of simplicity and chemical 
yield was achieved when the above sequence was directly 
carried out without protecting the C-3 hydroxy group, and the 
TEMPO/PhI(OAc)2 system was used in the oxidizing step in a 
one-pot oxidation-olefination process.[30] Thus, removal of the 
TIPS protecting group of 11, followed by chemoselective 
oxidation of the primary alcohol function with TEMPO and in situ 
Wittig homologation of the resulting aldehyde 19b, gave an α,β-
unsaturated ester, which was converted to DHQ-5-propionate 
21b via olefinic ester 20b, as in the above a series. 
To complete the functionalized eight-carbon chain of (+)-
lepadin D from the advanced intermediate 21b, it was necessary 
to perform a five-carbon elongation. After protection of the C-3 
hydroxy group as a TBDMS ether, LiAlH4 reduction of the ester 
group, followed by conversion of the resulting alcohol to an 
iodide using the I2-PPh3-imidazole protocol and subsequent 
reaction with sodium benzenesulfinate gave sulfone 22 (Scheme 
8).  
Coupling of the sulfonyl carbanion derived from 22 with the 
easily accessible epoxide (R)-propyloxirane[31] gave hydroxy 
sulfone 23 (mixture of epimers) in 60% yield. Finally, reductive 
desulfonylation with sodium amalgam, followed by simultaneous 
removal of the Boc and silyl protecting groups, completed the 
synthesis of (+)-lepadin D, in a total of 25 steps and 1.4% overall 
yield. Both the specific rotation and NMR data of our synthetic 




Scheme 8. Completion of the C-5 side chain. Enantioselective synthesis of 
(+)-lepadin D. 
Conclusions 
In conclusion, enantioselective synthetic routes to two 
stereochemical groups of lepadins have been developed from a 
common DHQ intermediate. The synthesis relies on the 
versatility of phenylglycinol-derived lactams as multipurpose 
scaffolds for the enantioselective construction of complex 
nitrogen-containing natural products. 
The main features of the synthesis are: i) the straightforward 
construction of a DHQ system bearing a functionalized one-
carbon substituent at the C-5 position; ii) the incorporation of the 
C-2 methyl and C-3 hydroxy substituents taking advantage of 
the lactam carbonyl; and iii) the elongation of the C-5 chain, 
either directly with a seven-carbon fragment (lepadins A-C) or 
sequentially using two- and five-carbon fragments (lepadin D). 
Key aspects from the stereochemical standpoint are: i) the 
stereoselective generation of the cis-DHQ ring fusion by 
reductive opening of the oxazolidine ring; ii) the control of the 
configuration of the C-5 stereocenter by stereoselective 
hydrogenation of a carbon-carbon double bond, either 
endocyclic in a tricyclic lactam or exocyclic in an N-unsubstituted 
DHQ derivative; iii) the installation of the trans 2-Me/3-OH 
relationship by a stereoselective hydroboration-oxidation 
sequence from a methyl-substituted N-Boc enamine, with 
subsequent inversion of the C-3 configuration via a ketone; and, 
finally, iv) the stereoselective achievement of the (E, E)-
configuration of the C-5 chain via a Horner-Wadsworth-Emmons 
reaction. 
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Using (R)-phenylglycinol as the 
source of chirality, the marine 
alkaloids (–)-lepadins A–C and (+)-
lepadin D, with opposite absolute 
configuration at the C-3 and C-5 ring 
positions, have been synthesized. The 
synthesis features the use of a 
tricyclic oxazoloquinolone lactam as 
the key enantiomeric scaffold and 
proceeds via an advanced common 
decahydroquinoline intermediate. 
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